| SUMMARY | Clinical trial that will guide Malawi health policy and ultimately affect the health of millions of antiretroviral therapy (ART) recipients by providing evidence to determine whether to stop TS prophylaxis in person on ART and the importance of preventing HIV-associated opportunistic infections and malaria in persons who are stable on ART |
